S
S2Medical AB (publ)
STO:S2M
S2Medical AB (publ)
STO:S2M
Price:
0.0086
SEK
-3.37%
Market Cap:
kr7.7m
Balance Sheet
Balance Sheet Decomposition
S2Medical AB (publ)
S2Medical AB (publ)
Balance Sheet Decomposition is not available for
S2Medical AB (publ)
S2Medical AB (publ)
Balance Sheet
S2Medical AB (publ)
S2Medical AB (publ)
Currency: SEK
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
1
|
2
|
5
|
36
|
15
|
25
|
9
|
4
|
2
|
1
|
|
| Cash |
1
|
2
|
5
|
36
|
15
|
25
|
9
|
4
|
2
|
1
|
|
| Total Receivables |
0
|
0
|
0
|
2
|
3
|
1
|
1
|
2
|
2
|
2
|
|
| Accounts Receivables |
0
|
0
|
0
|
1
|
2
|
1
|
1
|
1
|
1
|
2
|
|
| Other Receivables |
0
|
0
|
0
|
2
|
1
|
0
|
1
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
2
|
2
|
5
|
5
|
6
|
5
|
2
|
|
| Other Current Assets |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
1
|
|
| Total Current Assets |
2
|
3
|
6
|
42
|
21
|
32
|
16
|
12
|
9
|
6
|
|
| PP&E Net |
1
|
2
|
2
|
3
|
3
|
2
|
2
|
1
|
1
|
0
|
|
| Intangible Assets |
0
|
2
|
2
|
5
|
7
|
8
|
10
|
11
|
11
|
11
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
1
|
1
|
1
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
1
|
1
|
1
|
|
| Total Assets |
3
N/A
|
6
+84%
|
11
+74%
|
49
+339%
|
31
-37%
|
41
+35%
|
30
-28%
|
25
-15%
|
21
-15%
|
25
+18%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
0
|
0
|
0
|
1
|
2
|
4
|
1
|
2
|
3
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
1
|
2
|
3
|
3
|
3
|
3
|
4
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
1
|
1
|
1
|
11
|
14
|
13
|
3
|
|
| Total Current Liabilities |
0
|
1
|
1
|
4
|
5
|
8
|
15
|
18
|
20
|
7
|
|
| Long-Term Debt |
0
|
0
|
0
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
3
|
3
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
3
N/A
|
4
+6%
|
4
+3%
|
6
+46%
|
6
+1%
|
8
+52%
|
15
+77%
|
18
+22%
|
20
+8%
|
7
-66%
|
|
| Equity | |||||||||||
| Common Stock |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
2
|
16
|
1
|
|
| Retained Earnings |
0
|
0
|
5
|
40
|
19
|
50
|
70
|
99
|
135
|
103
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
82
|
84
|
104
|
120
|
120
|
|
| Other Equity |
0
|
2
|
2
|
3
|
5
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
0
N/A
|
3
+7 522%
|
7
+168%
|
44
+491%
|
25
-42%
|
33
+31%
|
15
-55%
|
7
-52%
|
2
-77%
|
19
+1 029%
|
|
| Total Liabilities & Equity |
3
N/A
|
6
+84%
|
11
+74%
|
49
+339%
|
31
-37%
|
41
+35%
|
30
-28%
|
25
-15%
|
21
-15%
|
25
+18%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
9
|
11
|
12
|
16
|
16
|
38
|
65
|
114
|
355
|
844
|
|
Switch to:
Switch to:
See Also
Discover More
